Andrew Saik

Insider Reports History

Entity
Individual
Location
640 Lee Road, Chesterbrook, PA
Signature
/s/ Jared Freedberg, as attorney-in-fact for Andrew Saik
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Saik:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARVINAS, INC. Chief Financial Officer Common Stock 111K $3.06M $27.69 Feb 13, 2025 Direct
ARVINAS, INC. Chief Financial Officer Stock Option (right to buy) 75K $1.2M $16.00 Feb 13, 2025 Direct
VYNE Therapeutics Inc. Chief Financial Officer Common Stock 116K $266K $2.28 May 28, 2021 Direct
Milestone Pharmaceuticals Inc. Director Stock Option (right to buy) 40K Aug 28, 2024 Direct
INTERCEPT PHARMACEUTICALS, INC. EVP & Chief Financial Officer Common Stock 0 $19.00 Nov 8, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. EVP & Chief Financial Officer Option to Purchase Common Stock 0 Nov 8, 2023 Direct

Insider Reports Filed by Andrew Saik

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARVN ARVINAS, INC. Feb 13, 2025 2 $0 4 Feb 18, 2025 Chief Financial Officer
MIST Milestone Pharmaceuticals Inc. Aug 28, 2024 1 $0 4 Aug 29, 2024 Director
MIST Milestone Pharmaceuticals Inc. Jul 15, 2024 1 $0 4 Jul 17, 2024 Director
MIST Milestone Pharmaceuticals Inc. Jul 15, 2024 0 $0 3 Jul 17, 2024 Director
ARVN ARVINAS, INC. Jun 24, 2024 2 $0 4 Jun 26, 2024 Chief Financial Officer
ARVN ARVINAS, INC. Jun 24, 2024 0 $0 3 Jun 26, 2024 Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 8, 2023 5 -$1.3M 4 Nov 13, 2023 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Sep 21, 2023 1 -$9.81K 4 Sep 25, 2023 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Jun 21, 2023 1 -$10.7K 4 Jun 23, 2023 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Mar 21, 2023 1 -$12.9K 4 Mar 23, 2023 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Jan 27, 2023 2 $0 4 Jan 31, 2023 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Dec 31, 2022 1 -$8.88K 4 Jan 3, 2023 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Dec 21, 2022 1 -$12.2K 4 Dec 23, 2022 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Sep 21, 2022 1 -$13.5K 4 Sep 23, 2022 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Jun 21, 2022 1 -$45.3K 4 Jun 23, 2022 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Jan 27, 2022 2 $0 4 Jan 31, 2022 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Jun 21, 2021 2 $0 4 Jun 22, 2021 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Jun 21, 2021 0 $0 3 Jun 22, 2021 EVP & Chief Financial Officer
VYNE VYNE Therapeutics Inc. May 28, 2021 1 $10.1K 4 Jun 2, 2021 Chief Financial Officer